Insider Buy/Sell Details for the Biotechnology Industry — Last 30 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (974)
Pharvaris N.V. (PHVS)
Modig Berndt — Director
Shares
2,291
Price
$39.40
Total Value
$90.28K
Shares Held After
128,334
% of Holdings
1.8%
RHYTHM PHARMACEUTICALS, INC. (RYTM)
Meeker David P — Director
Shares
2,300
Price
$105.19
Total Value
$241.94K
Shares Held After
239,258
% of Holdings
1.0%
RHYTHM PHARMACEUTICALS, INC. (RYTM)
Meeker David P — Director
Shares
1,817
Price
$104.55
Total Value
$189.96K
Shares Held After
241,558
% of Holdings
0.7%
RHYTHM PHARMACEUTICALS, INC. (RYTM)
Meeker David P — Director
Shares
8,698
Price
$103.43
Total Value
$899.63K
Shares Held After
243,375
% of Holdings
3.5%
RHYTHM PHARMACEUTICALS, INC. (RYTM)
Meeker David P — Director
Shares
30,746
Price
$102.35
Total Value
$3.15M
Shares Held After
252,073
% of Holdings
10.9%
RHYTHM PHARMACEUTICALS, INC. (RYTM)
Meeker David P — Director
Shares
6,439
Price
$101.75
Total Value
$655.15K
Shares Held After
282,819
% of Holdings
2.2%
BioNTech SE (BNTX)
Sahin Ugur — Chief Executive Officer
Shares
41,000
Price
$99.45
Total Value
$4.08M
Shares Held After
602,209
% of Holdings
6.4%
Pharvaris N.V. (PHVS)
Lu Peng — President
Shares
15,000
Price
$40.13
Total Value
$601.95K
Shares Held After
65,179
% of Holdings
18.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
280
Price
$508.21
Total Value
$142.30K
Shares Held After
324,443
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
320
Price
$507.31
Total Value
$162.34K
Shares Held After
324,723
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
518
Price
$506.44
Total Value
$262.34K
Shares Held After
325,043
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
82
Price
$504.97
Total Value
$41.41K
Shares Held After
325,561
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
710
Price
$503.99
Total Value
$357.83K
Shares Held After
325,643
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
850
Price
$503.10
Total Value
$427.63K
Shares Held After
326,353
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,560
Price
$502.13
Total Value
$783.32K
Shares Held After
327,203
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
476
Price
$500.86
Total Value
$238.41K
Shares Held After
328,763
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
204
Price
$499.61
Total Value
$101.92K
Shares Held After
329,239
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,021
Price
$498.97
Total Value
$509.45K
Shares Held After
329,443
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,138
Price
$497.99
Total Value
$1.06M
Shares Held After
330,464
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,341
Price
$496.74
Total Value
$666.13K
Shares Held After
332,602
% of Holdings
0.4%
BioNTech SE (BNTX)
Sahin Ugur — Chief Executive Officer
Shares
45,000
Price
$96.93
Total Value
$4.36M
Shares Held After
643,209
% of Holdings
6.5%
Korro Bio, Inc. (KRRO)
Dolan Oliver — Senior Vice President, Finance
Shares
5
Price
$13.72
Total Value
$68.58
Shares Held After
16,241
% of Holdings
0.0%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
4,508
Price
$107.55
Total Value
$484.83K
Shares Held After
767,780
% of Holdings
0.6%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
15,492
Price
$107.15
Total Value
$1.66M
Shares Held After
772,288
% of Holdings
2.0%
Aardvark Therapeutics, Inc. (AARD)
Sun Nelson — Chief Financial&Operating Officer
Shares
62,000
Price
$5.18
Total Value
$321.18K
Shares Held After
35,475
% of Holdings
63.6%
CYTOKINETICS INC (CYTK)
Landry Robert E — Director
Shares
1,000
Price
$74.66
Total Value
$74.66K
Shares Held After
9,184
% of Holdings
9.8%
Candel Therapeutics, Inc. (CADL)
Tak Paul Peter — Director
Shares
59,379
Price
$10.46
Total Value
$620.89K
Shares Held After
113,321
% of Holdings
34.4%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Sibold William John — Director
Shares
120
Price
$546.38
Total Value
$65.57K
Shares Held After
197,746
% of Holdings
0.1%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Sibold William John — Director
Shares
761
Price
$544.83
Total Value
$414.62K
Shares Held After
197,866
% of Holdings
0.4%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Sibold William John — Director
Shares
1,539
Price
$544.02
Total Value
$837.25K
Shares Held After
198,627
% of Holdings
0.8%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Sibold William John — Director
Shares
1,202
Price
$542.60
Total Value
$652.21K
Shares Held After
200,166
% of Holdings
0.6%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Sibold William John — Director
Shares
368
Price
$541.64
Total Value
$199.32K
Shares Held After
201,368
% of Holdings
0.2%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Sibold William John — Director
Shares
687
Price
$540.59
Total Value
$371.38K
Shares Held After
201,736
% of Holdings
0.3%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Sibold William John — Director
Shares
160
Price
$537.62
Total Value
$86.02K
Shares Held After
202,423
% of Holdings
0.1%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Sibold William John — Director
Shares
218
Price
$535.94
Total Value
$116.84K
Shares Held After
202,583
% of Holdings
0.1%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Sibold William John — Director
Shares
106
Price
$534.06
Total Value
$56.61K
Shares Held After
202,801
% of Holdings
0.1%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Sibold William John — Director
Shares
60
Price
$533.09
Total Value
$31.99K
Shares Held After
202,907
% of Holdings
0.0%
MANNKIND CORP (MNKD)
Binder Steven B. — Director
Shares
33,558
Price
$3.81
Total Value
$127.86K
Shares Held After
752,309
% of Holdings
4.3%
Jazz Pharmaceuticals plc (JAZZ)
Patil Neena M — EVP&Chief Legal Officer
Shares
1,200
Price
$240.94
Total Value
$289.13K
Shares Held After
47,671
% of Holdings
2.5%
Revolution Medicines, Inc. (RVMD)
Mancini Anthony — Chief Global Commercialization Officer
Shares
300
Price
$207.17
Total Value
$62.15K
Shares Held After
43,890
% of Holdings
0.7%
Revolution Medicines, Inc. (RVMD)
Mancini Anthony — Chief Global Commercialization Officer
Shares
1,179
Price
$206.10
Total Value
$242.99K
Shares Held After
44,190
% of Holdings
2.6%
Revolution Medicines, Inc. (RVMD)
Mancini Anthony — Chief Global Commercialization Officer
Shares
2,420
Price
$205.05
Total Value
$496.22K
Shares Held After
45,369
% of Holdings
5.1%
Revolution Medicines, Inc. (RVMD)
Mancini Anthony — Chief Global Commercialization Officer
Shares
5,530
Price
$204.14
Total Value
$1.13M
Shares Held After
47,789
% of Holdings
10.4%
Revolution Medicines, Inc. (RVMD)
Mancini Anthony — Chief Global Commercialization Officer
Shares
6,019
Price
$203.28
Total Value
$1.22M
Shares Held After
53,319
% of Holdings
10.1%
TG THERAPEUTICS, INC. (TGTX)
Charney Laurence N — Director
Shares
5,000
Price
$54.96
Total Value
$274.80K
Shares Held After
168,640
% of Holdings
2.9%
LIGAND PHARMACEUTICALS INC (LGND)
Zimmermann Martine — Director
Shares
1,200
Price
$285.00
Total Value
$342.00K
Shares Held After
3,897
% of Holdings
23.5%
Moderna, Inc. (MRNA)
Mock James M — Chief Financial Officer
Shares
15,000
Price
$134.49
Total Value
$2.02M
Shares Held After
59,375
% of Holdings
20.2%
Moderna, Inc. (MRNA)
Mock James M — Chief Financial Officer
Shares
19,836
Price
$134.49
Total Value
$2.67M
Shares Held After
74,375
% of Holdings
21.1%
Amylyx Pharmaceuticals, Inc. (AMLX)
Cohen Joshua B — Director
Shares
919
Price
$33.15
Total Value
$30.46K
Shares Held After
3,613,123
% of Holdings
0.0%
Amylyx Pharmaceuticals, Inc. (AMLX)
Cohen Joshua B — Director
Shares
29,545
Price
$32.16
Total Value
$950.04K
Shares Held After
3,614,042
% of Holdings
0.8%
Showing 1–50 of 974 transactions (page 1 of 20)